📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

AB0017 HOW DO B CELLS EVADE RITUXIMAB THERAPY IN AUTOIMMUNITY; IS IT TIME TO TARGET THE CD19+CD20- B CELLS? (2023)

First Author: Shah K

Attributed to: Modulating Metabolic Programming of Memory B cell Activation to Restore B-cell Homeostasis in Autoimmune Disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/annrheumdis-2023-eular.2442

Publication URI: http://dx.doi.org/10.1136/annrheumdis-2023-eular.2442

Type: Journal Article/Review

Parent Publication: Annals of the Rheumatic Diseases